Never miss an important update on your stock portfolio and cut through the noise. Over 7 million investors trust Simply Wall St to stay informed where it matters for FREE.
ICU Medical is back in focus as bullish analysts lift price targets into the high $170s to $180 range, while the model fair value remains unchanged at $182.67. These moves are tied to higher estimates into 2026 and recent quarterly results that analysts view as supportive for slightly stronger EBITDA and EPS, even as they note that the 2026 guidance is more in line than aggressive. Read on to see what is driving this evolving narrative and how you can track it as new data comes in.
Analyst Price Targets don’t always capture the full story. Head over to our Company Report to find new ways to value ICU Medical.
-
KeyBanc lifted its ICU Medical price target to $180 from $175, pointing to higher…
